Share >  
Share
Share on Tumblr

Fda

News »

   latest by relevance
Ranbaxy whistleblower pockets $48.5mn for settlement
May 15, 2013 at 19:19 | Source: CNBC-TV18
CNBC-TV18s Archana Shukla takes a closer look at Dinesh Thakur, the man who blew the whistle on Ranbaxy, and kicked off a legal battle that other generic drug makers will take notes from
Ranbaxy pleads guilty to felony; agrees to pay USD 500m
May 14, 2013 at 18:28 | Source: CNBC-TV18
In a settlement with the US FDA at the US department of Justice, Ranbaxy has pleaded guilty to felony charges. This is a culmination of the consent degree that the company had signed in end-2011 with the US Food and Drug Administration.
Ranbaxy shrugs off US lawsuit settlement; ends up 4%
May 14, 2013 at 18:11 | Source: Moneycontrol.com
Ranbaxy Labs shares recovered from early losses and ended up 3.6 percent on NSE on Tuesday. The company has agreed to settle all alleged civil violations with the US and its US arm is also pleading guilty to criminal charges related to Food, Drugs act.
Ranbaxy whistleblower Thakur richer by Rs 266cr; speaks out
May 14, 2013 at 11:50 | Source: Moneycontrol.com
Dinesh Thakur served as the whistleblower in this case and is the former Ranbaxy Director and Global Head, Research Information & Portfolio Management. Thakur is entitled to Rs 266 crore as the whistleblower in the case, the US Justice Department said.
Not worried about Re; bet on Exide, Sun Pharma, Bharti: UBS
May 14, 2013 at 10:47 | Source: CNBC-TV18
Suresh Mahadevan, MD & Head of Indian Equities, UBS Securities is of the opinion that Nifty will end 2013, at higher end of 5600-6450 range and sees FY14 earnings growth being slightly lower than 15-16%.
Ranbaxy shrs fall on USD 500mn US lawsuits settlement
May 14, 2013 at 09:31 | Source: Moneycontrol.com
Ranbaxy said its US arm is pleading guilty to criminal charges related to violation of the Food, Drugs and Cosmetics Act and the company. owned by Japan's Daiichi Sankyo, will now pay USD 500 million to settle all the civil, criminal lawsuits.

Videos »
Ranbaxy whistleblower pockets $48.5mn for settlement
Ranbaxy pleads guilty to felony; agrees to pay USD 500m
Not worried about Re; bet on Exide, Sun Pharma, Bharti: UBS
Hold Ranbaxy, target of Rs 509: Sharmila Joshi
Glenmark: Environment challenging, see 20% growth in FY14
more »

Photos »

  /  
News across the web »
Unauthorised factory selling heart kits to Delhi hospitals sealed
Chandigarh, May 16 (IANS) The Haryana Food and Drug Administration (FDA) has sealed an unauthorised factory which was selling medical devices, especially heart kits, to hospitals in national capital, ...
May 17, 2013 at 05:30 | Source: FirstPost
After swallowing bitter pill, Ranbaxy set to revive sales to US
New York: How will Ranbaxys $500 million fraud settlement affect its business in the United States? The settlement is the largest in history involving a generic manufacturer and drug safety, according...
May 16, 2013 at 08:28 | Source: FirstPost
Meet the man who made $49 mn by blowing the whistle on Ranbaxy
Dinesh Thakur, the whistleblower in Ranbaxy Laboratories' US drug safety case, has made a killing by blowing the lid off the dubious manufacturing practices of the pharma major that has pleaded guilty...
May 15, 2013 at 13:22 | Source: FirstPost
Ranbaxy to pop rebuild pill
Mumbai, May 14: The real challenge for Ranbaxy begins now after it admitted felony charges and agreed to pay $500 million to settle charges that it had marketed adulterated drugs in the US made at it...
May 15, 2013 at 04:47 | Source: Calcutta Telegraph News
Ranbaxy recovers; U.S. fine overhang seen ending
Reuters Market Eye - Ranbaxy Laboratories Ltd(RANB.NS) shares recovered on Tuesday as U.S. fine overhang was seen ending.Shares in Ranbaxy Laboratories Ltd (RANB.NS) gained 3 percent, after earlier de...
May 14, 2013 at 23:45 | Source: FirstPost
more »
Interact & exchange stock tips & market info »

manishnb

Platinum Member

49 Followers

Wockhardt  

warning letter may ban export of injectables if not satisfy to FDA

6.31 PM May 20th

tubes

Platinum Member

34 Followers

Sun Pharma  

Sun does not have 180 days exclusivity for ZOMETA -zolendronic acid. Y...

11.18 PM May 19th

tubes

Platinum Member

34 Followers

Sun Pharma  

It already has FDA approval for finasteride.I am not sure about...

11.01 PM May 19th

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window